Immunotherapy for rheumatoid arthritis mainly includes traditional synthetic anti-rheumatic drugs, targeted synthetic anti-rheumatic drugs and biological anti-rheumatic drugs.
1. Traditional synthetic anti-rheumatic drugs to improve the condition: such as methotrexate, salazosulfapyridine, leflunomide, etc. The effect of these drugs is relatively slow, although they can effectively improve the condition, slow down and prevent the joints from deformation, but not every patient will have a significant effect on each kind of drug. At the same time, these drugs have a certain effect on the blood and liver system, and regular checkups are required during the period of taking the drugs.
2. Targeted synthetic anti-rheumatic drugs to improve the condition: these drugs target intracellular signaling molecules and are small molecule drugs, including Barettib and Tofacitib.
3. Biological anti-rheumatic drugs to improve the condition: including adalimumab, infliximab, etanercept, etc. These drugs can effectively control joint inflammation and reduce bone destruction by inhibiting IL-6, TNF-a and other immunosuppressive effects.
Drugs should be used under the guidance of a physician, and it is recommended that patients go to the rheumatology and immunology department of a regular hospital, and choose the appropriate medication under the guidance of the doctor according to their individual conditions.